Alyeska Investment Group
MRNA icon

Alyeska Investment Group’s Moderna MRNA Stock Holding History

Alyeska Investment Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39.3M Sell
560,819
-3,490,366
-86% -$181M 0.1% 239
2026
Q1 		$206M Buy
4,051,185
+822,654
+25% +$38.4M 0.58% 34
2025
Q4 		$95.2M Buy
+3,228,531
New +$87.7M 0.27% 105

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Alyeska Investment Group's MRNA Position: Q2 2026 in Review

Alyeska Investment Group reduced its Moderna (MRNA) stake by 86% in Q2 2026, selling an estimated $181M and leaving 560,819 shares worth $39.3M. The position accounts for 0.1% of the portfolio, ranked #239.

Alyeska Investment Group first reported a position in MRNA in Q4 2025 and has held it in 3 quarters since. The position peaked at $206M in Q1 2026. 777 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Alyeska Investment Group held 560,819 shares of Moderna worth $39.3M as of Q2 2026.
  • Alyeska Investment Group sold 3,490,366 Moderna shares in Q2 2026, an estimated $181M.
  • Moderna made up 0.1% of Alyeska Investment Group's portfolio in Q2 2026, its #239 holding.
  • Alyeska Investment Group first reported a position in Moderna in Q4 2025 and has held it in 3 quarters since.
  • Alyeska Investment Group's Moderna position peaked at $206M in Q1 2026.
  • 777 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Alyeska Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.